8/14/2024GSK Launches Phase 3 Trial for RSV Vaccine in China

8/14/2024Apollomics Announces Positive Preliminary Data of Vebreltinib

8/13/2024AstraZeneca and Daiichi Sankyo Secure Third Approval For Enhertu in Ch...

8/13/2024Junshi's sNDA for Toripalimab as First-Line Treatment of Unresectable/...

8/13/2024MNC Pharma Companies in China Return to Growth after Years of VBP Turb...

8/13/2024OcuMension Acquires China Rights to Alcon Eye Drops with 16.7% Equity ...

8/12/2024Genor License ex-China Rights for CD20/CD3 Bispecific to TRC 2004

8/9/2024Recent Executive Moves

8/9/2024LTZ Thera Announces Over $20M Series A Financing for Its Myeloid Engag...

8/9/2024SEED Thera Partners with Eisai in Strategic Collaboration for Novel Mo...

8/9/2024WuXi, Medigene Team Up for T Cell-activating Cancer Therapies

8/9/2024Cullinan Returns Bispecific to Harbour BioMed One Year After Paying $2...

8/9/2024Merck to Acquire Investigational B-Cell Depletion Therapy from Curon

8/9/2024Sable Thera Announces Worldwide Licensing Deal with Columbia Univers...

8/8/2024Pharma services boom in China as CPHI & PMEC China posts record attend...

8/8/2024WestGene Secures Dual IND Approvals for mRNA Cancer Vaccine Targeting ...

8/8/2024Roche Launches Novel Pediatric Flu Drug in China

8/8/2024Astellas Pharma Targets China for R&D Growth and Global Impact

8/8/2024CDE Solicits Public Comments on the Technical Guidelines for Clinical ...

8/7/2024Uncertainty Looms Over Gardasil's Future in China

8/7/2024A Share-listed Biopharma Cos Saw Positive Trends in H1/2024 with Incre...

8/7/2024NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...

8/7/2024Santen and Cloudbreak Execute A New Licensing Agreement

8/6/2024NMPA Solicits Feedbacks on the Regulations on the Regulation of Export...

8/6/2024Huadong to Pay $150M for Right to Market ImunoPharm's Novel Anticance...

8/6/2024Asymchem Inaugurates New Site in Sandwich, UK

8/6/2024Organon Reports Falling China Sales in Q2/2024 Impacted by VBP

8/5/2024China Deepens Medical Reform through "Health-first Strategy

8/5/2024CR Sanjiu to Acquire 33% Stake in Tasly Pharma Group for $869M

8/5/2024Genmab Assumes Full Ownership of Acasunlimab after BioNTech Exits Part...

Page:23/42 Total number of articles:1234: [First][<<] [21] [22] [23] [24] [25] [>>] [End]